Radiation for Oligometastatic Lung Cancer in the Era of Immunotherapy: What Do We (Need to) Know?

Stephanie T. H. Peeters*, Evert J. Van Limbergen, Lizza E. L. Hendriks, Dirk De Ruysscher

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Article number2132
Number of pages14
JournalCancers
Volume13
Issue number9
DOIs
Publication statusPublished - May 2021

Keywords

  • non-small cell lung cancer
  • immunotherapy
  • radiotherapy
  • immune checkpoint inhibitor
  • oligometastatic
  • LOCAL CONSOLIDATIVE THERAPY
  • PROGRESSION-FREE SURVIVAL
  • PHASE-II
  • MAINTENANCE THERAPY
  • PROGNOSTIC-FACTORS
  • PRIMARY TUMOR
  • RADIOTHERAPY
  • IMMUNE
  • METASTASIS
  • MECHANISMS

Cite this